126 related articles for article (PubMed ID: 38286271)
81. Transcription Factor FOXO3a Overexpression Inhibits the Progression of Neuroblastoma by Regulating the miR-21/SPRY2/ERK Axis.
Chen J; Xu Y; Wu P; Chen X; Weng W; Li D
World Neurosurg; 2022 Aug; 164():e99-e112. PubMed ID: 35405317
[TBL] [Abstract][Full Text] [Related]
82. Glucocorticoid receptor activation signals through forkhead transcription factor 3a in breast cancer cells.
Wu W; Zou M; Brickley DR; Pew T; Conzen SD
Mol Endocrinol; 2006 Oct; 20(10):2304-14. PubMed ID: 16690749
[TBL] [Abstract][Full Text] [Related]
83. PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer.
Liu W; Sui F; Liu J; Wang M; Tian S; Ji M; Shi B; Hou P
Oncotarget; 2016 Aug; 7(34):54744-54757. PubMed ID: 27458157
[TBL] [Abstract][Full Text] [Related]
84. [FOXO3a signaling pathway in prostate cancer: Progress in studies].
Tao Y; Li LL; Liu SH; Hong M
Zhonghua Nan Ke Xue; 2020 Aug; 26(8):745-750. PubMed ID: 33377739
[TBL] [Abstract][Full Text] [Related]
85. Exendin-4 promotes the vascular smooth muscle cell re-differentiation through AMPK/SIRT1/FOXO3a signaling pathways.
Liu Z; Zhang M; Zhou T; Shen Q; Qin X
Atherosclerosis; 2018 Sep; 276():58-66. PubMed ID: 30036742
[TBL] [Abstract][Full Text] [Related]
86. c-Jun, Foxo3a, and c-Myc Transcription Factors are Key Regulators of ATP-Mediated Angiogenic Responses in Pulmonary Artery Vasa Vasorum Endothelial Cells.
Strassheim D; Karoor V; Nijmeh H; Weston P; Lapel M; Schaack J; Sullivan T; Dempsey EC; Stenmark KR; Gerasimovskaya E
Cells; 2020 Feb; 9(2):. PubMed ID: 32054096
[TBL] [Abstract][Full Text] [Related]
87. Targeted Regulation of FoxO3a by miR-372 to Mediate Gastric Carcinoma Cell Apoptosis and DDP Drug Resistance.
Wang C; Wang C; Qiu C; Su Z
Cancer Biother Radiopharm; 2020 Dec; 35(10):753-759. PubMed ID: 32379491
[No Abstract] [Full Text] [Related]
88. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.
Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I
Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104
[TBL] [Abstract][Full Text] [Related]
89. Potent FOXO3a Activators from Biologically Active Compound Library for Cancer Therapeutics: An in silico Approach.
Manoharan S; Vedagiri H; Perumal E
Appl Biochem Biotechnol; 2023 Aug; 195(8):4995-5018. PubMed ID: 37017892
[TBL] [Abstract][Full Text] [Related]
90. The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis.
Sarkar M; Khare V; Guturi KK; Das N; Ghosh MK
Oncogene; 2015 Nov; 34(47):5843-56. PubMed ID: 25745998
[TBL] [Abstract][Full Text] [Related]
91. Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma.
Wang JG; Zheng XX; Zeng GY; Zhou YJ; Yuan H
Oncol Rep; 2014 Jan; 31(1):488-96. PubMed ID: 24247909
[TBL] [Abstract][Full Text] [Related]
92. Forkhead Box O3a requires BAF57, a subunit of chromatin remodeler SWI/SNF complex for induction of p53 up-regulated modulator of apoptosis (Puma) in a model of Parkinson's disease.
Sanphui P; Kumar Das A; Biswas SC
J Neurochem; 2020 Sep; 154(5):547-561. PubMed ID: 31971251
[TBL] [Abstract][Full Text] [Related]
93. MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease.
Hartmann D; Fiedler J; Sonnenschein K; Just A; Pfanne A; Zimmer K; Remke J; Foinquinos A; Butzlaff M; Schimmel K; Maegdefessel L; Hilfiker-Kleiner D; Lachmann N; Schober A; Froese N; Heineke J; Bauersachs J; Batkai S; Thum T
Circulation; 2016 Dec; 134(24):1973-1990. PubMed ID: 27780851
[TBL] [Abstract][Full Text] [Related]
94. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
Fang L; Wang H; Zhou L; Yu D
Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
[TBL] [Abstract][Full Text] [Related]
95. Akt-FOXO3a signaling affects human endothelial progenitor cell differentiation.
Mogi M; Walsh K; Iwai M; Horiuchi M
Hypertens Res; 2008 Jan; 31(1):153-9. PubMed ID: 18360030
[TBL] [Abstract][Full Text] [Related]
96. Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance.
Gomes AR; Zhao F; Lam EW
Chin J Cancer; 2013 Jul; 32(7):365-70. PubMed ID: 23706767
[TBL] [Abstract][Full Text] [Related]
97. FOXO3a: a novel player in thyroid carcinogenesis?
Karger S; Weidinger C; Krause K; Sheu SY; Aigner T; Gimm O; Schmid KW; Dralle H; Fuhrer D
Endocr Relat Cancer; 2009 Mar; 16(1):189-99. PubMed ID: 18845647
[TBL] [Abstract][Full Text] [Related]
98. Overexpression of Forkhead Box O3a and Its Association With Aggressive Phenotypes and Poor Prognosis in Human Hepatocellular Carcinoma.
Ahn H; Kim H; Abdul R; Kim Y; Sim J; Choi D; Paik SS; Shin SJ; Kim DH; Jang K
Am J Clin Pathol; 2018 Jan; 149(2):117-127. PubMed ID: 29365018
[TBL] [Abstract][Full Text] [Related]
99. Protein phosphatase 2A reactivates FOXO3a through a dynamic interplay with 14-3-3 and AKT.
Singh A; Ye M; Bucur O; Zhu S; Tanya Santos M; Rabinovitz I; Wei W; Gao D; Hahn WC; Khosravi-Far R
Mol Biol Cell; 2010 Mar; 21(6):1140-52. PubMed ID: 20110348
[TBL] [Abstract][Full Text] [Related]
100. HDAC4 regulates vascular inflammation via activation of autophagy.
Yang D; Xiao C; Long F; Su Z; Jia W; Qin M; Huang M; Wu W; Suguro R; Liu X; Zhu Y
Cardiovasc Res; 2018 Jun; 114(7):1016-1028. PubMed ID: 29529137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]